Substance / Medication

Adenosine triphosphate

SNOMED 76711004 UMLS C0001480

Overview

Active Ingredient

adenosine triphosphate

RxNorm CUI

318

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Paroxysmal tachycardia

Ventricular pre-excitation with arrhythmia

Re-entrant atrioventricular node tachycardia

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

Total Trials

Recruiting

With Results

Recent Trials

"Steroids and Azathioprine Versus Steroids Alone in IgAN"

NCT00755859Phase 4Completed206 enrolled

View all 1 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

FFadenosine triphosphate (ATP) synthase is a potential drug target in non-communicable diseases.

Singh Varsha · Mol Biol Rep · 2023

PMID: 36715790Meta-Analysis

Adenosine triphosphate/adenosine guided pulmonary vein isolation does not improve the outcomes of ablation: a meta-analysis of randomized controlled trials.

Afzal Muhammad R, Kahaly Omar, Weiss Raul et al. · Expert Rev Cardiovasc Ther · 2018

PMID: 29561176Meta-Analysis

Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trial.

Al-Khazali Haidar M, Deligianni Christina I, Pellesi Lanfranco et al. · Pain · 2024

PMID: 38127692RCT

Acute Effect of Oral Adenosine Triphosphate (ATP) Supplementation on Muscular Performance in Trained Adults.

Fambrini Danilo Luiz, Campos Neto Eurico Lara de, Ferreira Dos Santos Claudinei · J Am Nutr Assoc · 2024

PMID: 38193939RCT

Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose Finding.

Ruiz A, Sánchez D, Lafuente A et al. · J Prev Alzheimers Dis · 2022

PMID: 35841243RCT

A pilot study on the biochemical effects of repeated administration of 24% oral sucrose vs. 30% oral dextrose on urinary markers of adenosine triphosphate degradation.

Angeles Danilyn M, Boskovic Danilo S, Deming Douglas et al. · J Perinatol · 2021

PMID: 34671099RCT

Pace capture and adenosine triphosphate provocation are complementary rather than mutually exclusive methods to ensure durable pulmonary vein isolation.

Zeng Li-Jun, Shi Liang, Tian Ying et al. · J Cardiovasc Electrophysiol · 2019

PMID: 30891845RCT

Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate.

Nakayama Masafumi, Chikamori Taishiro, Uchiyama Takashi et al. · Cardiovasc Interv Ther · 2018

PMID: 28110424RCT

Interaction of Beta-Hydroxy-Beta-Methylbutyrate Free Acid and Adenosine Triphosphate on Muscle Mass, Strength, and Power in Resistance Trained Individuals.

Lowery Ryan P, Joy Jordan M, Rathmacher John A et al. · J Strength Cond Res · 2016

PMID: 24714541RCT

Antihyperlipidemic activity of adenosine triphosphate in rabbits fed a high-fat diet and hyperlipidemic patients.

Zhang Lianshan, Liang Libin, Tong Tong et al. · Pharm Biol · 2016

PMID: 26955742RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Adenosine triphosphate (substance)
SNOMED CT: 76711004
UMLS CUI: C0001480
RxNorm CUI: 318

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.